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TITLE OF CASE Do not include “a case report” 
Orbital mass secondary to infantile acute lymphoblastic leukaemia  
 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online)  
An 8-month-old Asian female infant was referred with a one-week history of left periorbital 
swelling on a background of a narrowed left palpebral aperture over the preceding 8 weeks. 
There was no history of chronic illness, fever or other systemic features. Examination 
revealed a tender and fluctuant medial canthal swelling with associated periorbital 
haematoma. There were no other ophthalmic findings and neurological examination was 
normal. A MRI scan of the brain and orbit demonstrated abnormal soft tissue with features of 
an aggressive tumour in the left orbital region with no globe invasion. Peripheral blood 
smear revealed blast cells, confirmed by bone marrow aspirate. A diagnosis of infant acute 
lymphoblastic leukaemia was made. The patient was started on risk-stratified chemotherapy 
according to the Interfant-06 Protocol. The periorbital swelling resolved by day eight 
following a course of prednisolone, the patient continues on chemotherapy and is currently in 
molecular remission.        
 
BACKGROUND Why you think this case is important – why did you write it up? 
Orbital masses secondary to acute lymphoblastic leukaemia (ALL) are a rare entity, with only 
seven cases reported in the literature, five of which were known to already have a systemic 
diagnosis.(1) Only 10% of orbital tumours in childhood are due to leukaemias and 
lymphomas, with granulocytic sarcomas secondary to acute myelogenous leukaemia (AML) 
being the most prevalent.(2) This patient was misdiagnosed with unilateral conjunctivitis, 
revised to dacryocystitis, and finally referred to our tertiary referral centre with an extensive 
dacryocele. ALL was found to be infiltrating the orbit as the sole presenting feature. Due to 
the misdiagnosis and delay in referral, it is important to highlight more sinister cases of 
orbital swelling as a potential differential diagnosis.   
 
CASE PRESENTATION Presenting features, medical/social/family history 
An 8-month-old Asian female infant was referred to the Ophthalmology department at Great 
Ormond Street Hospital (UK) with a one-week history of left periorbital swelling, preceded by 
an eight-week history of a narrowed left palpebral aperture. This was initially treated as 
conjunctivitis and then dacryocystitis. There was no fever, weight loss or other systemic 
features reported. There was no significant medical or family history and the baby was 
previously healthy with normal development.  
 
On examination, the patient was afebrile and appeared comfortable, alert and interactive. 
External examination revealed extensive swelling around the left medial canthus extending 
into the periorbital region with evidence of haematoma (Fig 1A). The palpebral aperture in 
the left eye was smaller than the right. The patient was able to fix and follow, and using 
forced choice preferential looking Teller acuity cards, the visual acuity was 6 cpd in both eyes 
(6/45), and there was no strabismus. Pupils were equally reactive to light with no relative 
afferent pupillary defect. Slit lamp examination revealed no anterior segment abnormalities, 
and fundus examination was normal with healthy optic disc, macula and peripheral retina. 
Regional examination of the lymph nodes revealed a 1 cm enlarged, firm, mobile occipital 
node on the left. On auscultation of the chest, there was diffuse bilateral wheeze. Tonsils 
were also enlarged. Abdomen was distended but soft and non-tender. Liver and spleen were 
4 cm and 3 cm below the costal margin, respectively. Neurological and cardiovascular 
examinations were normal.  
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INVESTIGATIONS If relevant 
An urgent MRI of the brain and orbit was performed (Fig 1C, D). This revealed abnormal soft 
tissue in the left orbital region with radiological features of an aggressive tumour such as 
neuroblastoma or rhabdomyosarcoma. The tumour was found to invade the left medial 
aspect of the orbit with extension into the extraconal fat, muscle orbicularis, anterior 
ethmoidal cells, radix of the nose, and the subcutaneous infraorbital fat tissue reaching the  
superior  alveolar  process  of  the mandible (highlighted by white arrows).  There was 
minimal mass effect on the left globe with no invasion or intracranial extension noted. 
 
Laboratory studies included: Full blood count which discovered neutropenia, 
thrombocytopenia and anaemia with WBC 21 × 109/L (high), platelets 10 × 109/L (low) and 
haemoglobin 75 g/L (low). Total white cell count was increased for age when examined in 
the peripheral blood smear; showing a majority of total white blood cells (80%) with 
immature appearances consistent with lymphoid blasts.  Bone marrow aspiration revealed 
ALL with blast rate representing 80% of total bone marrow events. Immunophenotypic  
markers (CD10-87%, CD19-100%, CD34-0%, CD38-100%, CD44-80%, and CD45-100%) 
were consistent with precursor B-cell ALL. Expression levels of CD45 and CD38 are typically 
observed in pre B-cell ALL, however the remaining phenotypic picture with CD10 expression 
on 87% of blasts would suggest common/pre B-cell ALL.	   Cytogenetic analysis of this 
patient's bone marrow cultures showed what appeared to be a normal karyotype (46,XX) 
with no identifiable abnormal clone in twenty-three metaphase spreads examined (sixteen 
metaphase spreads fully analysed and seven metaphases screened). Interphase FISH 
analysis identified a KMT2A rearrangement i.e. rearrangement of the mixed lineage leukemia 
(MLL) gene in 45.5% of nuclei. We have examined 202 interphase nuclei using an 
Abbott/Vysis dual-colour, break-apart probe set for the KMT2A (11q23, red/green fusion) 
region; 92/202 (45.5%) nuclei examined showed a positive signal pattern for a KMT2A 
rearrangement. Metaphase FISH identified a derived chromosome 11 in two metaphase 
spreads but due to poor chromosomal morphology, the KMT2A partner was unable to be 
reliably identified. 
 
The cerebrospinal fluid obtained by lumbar puncture was clear of leukaemic blast cells.  
 
DIFFERENTIAL DIAGNOSIS If relevant 
There are age-specific trends in the incidence of disorders causing orbital swelling, which aid 
the diagnostic process. For children under 2 years of age, the major causes are infantile peri-
ocular haemangiomas, lymphangiomas, and dermoid cysts, which tend to be slow growing. 
Acute onset signs may arise through a haemorrhage from a pre-existing vascular lesion, or 
an infective cause resulting in pre-septal or orbital cellulitis.  Rapidly increasing proptosis 
with periorbital swelling and ecchymosis is suggestive of a rapid-growing tumour such as 
rhabdomyosarcoma or neuroblastoma. The main differential diagnoses to consider are:  
1. Vascular: Venous-lymphatic malformations e.g. infantile peri-ocular haemangioma, 
lymphangioma  
2. Infective: Dacryocystitis, orbital cellulitis, pre-septal cellulitis  
3. Tumour: Neuroblastoma, rhabdomyosarcoma, retinoblastoma, granulocytic sarcoma 
(AML), optic nerve glioma, dermoid cyst 
 
Infantile peri-ocular haemangiomas appear by 6 months of age, are characterised by a 
period of rapid growth in the first year, followed by regression over the proceeding years. 
Lymphangiomas infrequently present in early childhood, they do not regress and can be 
complicated by sudden haemorrhage with rapidly progressive enlargement. Characteristic 
cutaneous lesions can be diagnosed clinically, however, most will require ultrasound and 
CT/MRI to delineate the tumour with its intrinsic blood flow.  
 
Children with pre-septal cellulitis present with fever, malaise, painful swollen inflamed lids, 
but no proptosis, normal eye movements and normal optic nerve function. This is in contrast 
to those with orbital cellulitis who do show proptosis, restricted eye movements, and 
potentially optic nerve compromise.  
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Neuroblastoma accounts for most childhood orbital metastatic disease under the age of 3. 
Rhabdomyosarcoma and retinoblastoma are the most important sources of secondary orbital 
disease, although the latter is usually confined intraocularly but in advanced cases may 
extend into the orbit. Optic nerve gliomas and dermoid cysts are slow growing. There are a 
number of other rare tumours but as a group they are difficult to distinguish clinically and 
biopsy is recommended for confirmation.  
TREATMENT If relevant  
The patient was started on chemotherapy as per the Interfant-06 Protocol. This is the 
international collaborative treatment protocol for infants under the age of 1 with ALL. 
Patients are stratified into low, medium or high risk based upon age, white cell 
count/prednisolone response and MLL status. This patient was categorised into medium risk 
and urgently commenced on oral prednisolone 60 mg/m2/day according to the induction 
block of chemotherapy. 
 
OUTCOME AND FOLLOW-UP   
The periorbital swelling resolved by day eight (Fig 1B). The prednisolone response was good 
and subsequently the patient continued with chemotherapy treatment on the standard 
medium risk arm. At the end of the induction chemotherapy block our patient was in 
molecular remission. Providing the patient remains in complete remission at all follow-up 
time points, 5 blocks of chemotherapy will be completed in total.  
 
In terms of prognosis, infants with ALL do far worse than older children. Interfant-99, the 
largest collaborative trial to date of infantile ALL reported 4-year event free survival (EFS) of 
47% with considerable variation in outcome between different risk groups.(3) Infants with 
ALL defined as low risk had a 4-year EFS of 74%, medium risk 44.8%, and high risk 19.8%. 
Even though most treatment failures are related to relapse of disease, treatment-related 
mortality and life-limiting late effects in survivors are significant.  
 
 
DISCUSSION Include a very brief review of similar published cases  
Infantile acute lymphoblastic leukaemia is rare, contributing to ~2-4% of all childhood 
ALL.(4) It is biologically distinct from the disease in older children and associated with a 
poorer prognosis. Infants are more likely to present with high leucocyte counts, 
hepatosplenomegaly and overt neurological disease.(5) The vast majority (70-80%) of 
infants with ALL express cytogenetic abnormality by chromosomal translocations involving 
the MLL gene at chromosome 11q23.(6) Independent prognostic factors of outcome in infant 
ALL include  status of the MLL gene, CD10 expression, age at diagnosis, white blood cell 
count at presentation, central nervous system involvement, co-expression of myeloid 
markers, and early response to prednisone.(7) 
 
It is unclear if this infant girl presented with primary orbital or systemic ALL, as the initial 
focus was the periorbital swelling, causing a deflection from any systemic features, which 
were later found on presentation to our institution. A more careful consideration to the 
extra-ocular clinical data and blood counts may have hastened the diagnosis of this child.  
There is only one other report in the literature of an infant presenting with similar orbital 
involvement.(8)  There are a further 6 cases reported of childhood orbital ALL, 5 with a 
confirmed systemic diagnosis, and only one in a 3 year old with primary orbital 
presentation.(9)(10)  
 
Ophthalmic signs in patients suffering from leukaemia was first described as ‘leukemic 
retinopathy’ by Liebreich in 1863, and although reports of patients with ALL presenting with 
ophthalmic symptoms as the initial sign of the disease is rare, ocular changes during the 
disease is common.(11) Ophthalmic manifestations are due to the accumulation of blast cells 
secondary to bone marrow failure, and include extraocular muscle, optic nerve and 
intraocular infiltration. Ocular involvement is associated with a poor prognosis and increase 
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risk of relapse. One study found that the five year survival rate was 21.4% in children with 
leukaemic ocular involvement compared to 45.7% in those that did not.(12) Many of these 
lesions are asymptomatic, therefore it is important to consider ophthalmic evaluation at the 
time of diagnosis of ALL as well as in monitoring relapse.  
 
There was a lack of investigative rigour in treatments for infantile ALL. This is due to the 
rarity of the disease, making it hard to design clinical trials with sufficient numbers. For this 
reason, in 1999, 17 different study groups across 20 nations participated in an international 
collaborative clinical trial, Interfant-99, which was subsequently revised to Interfant-06 in 
2006, to include early intensified regimens to reduce relapse. With multi-agent, risk-
stratified regimens, 90-95% of infants with ALL can achieve remission after initial induction 
therapy.(13) Although the survival rate has improved, in the last decade it has remained 
stagnant and the longterm outcome for MLL-rearrangement infantile ALL, such as in our 
case, still remains suboptimal i.e. 4-year EFS of 44.8%. The future of infant ALL therapy will 
revolve around molecular targets, which focus on prognostic markers such as genetic 
factors. The challenge now is to identify the most appropriate target for future clinical trials. 
The FMS-like tyrosine kinase 3 (FLT3) inhibitor, CEP-701, is the first novel agent to be 
investigated in a large collaborative clinical trial for MLL-rearrangement infantile ALL and is 
currently underway.(14)   
 
  
 
 
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
• Infant acute leukaemia is a poor prognostic entity that should be considered as a rare 
differential diagnosis of persistent orbital swellings that otherwise appear to be 
caused by typical local infectious/inflammatory pathologies. 
• A thorough physical examination and careful attention to the blood counts as well as 
early referral may help minimise diagnostic delay in these babies. 
• Ocular involvement in patients with leukaemia is associated with a poorer prognosis 
and increased risk of relapse.  
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
 
Figure 1 (A) Patient with extensive left medial canthal swelling at presentation, and (B) after 
8-days on prednisolone the periorbital swelling resolved. (C) Axial MRI T2-weighted image 
demonstrating a tumour invading the left medial aspect of the orbit with extension to the 
extraconal fat, and (D) a coronal view showing invasion into the orbicularis oculi, anterior 
ethmoid cells, radix of the nose and subcutaneous infraorbital fat tissue reaching the 
superior alveolar process of the mandible.  
 
 
 
 
PATIENT’S PERSPECTIVE Optional but strongly encouraged – this has to be written 
by the patient or next of kin 
“It would be an understatement to say that I was shocked when I learnt that my baby had 
cancer. Initially, I was told by a number of services that it was an infection, but I knew 
something was wrong but felt no-one was listening. My daughter has leukaemia, I accept 
that, but I’m more frustrated at how long it took to find this out. I realise that her 
presentation was extremely rare, but even the basic tests such as a blood test was 
overlooked and not done in the initial phases. My message to doctors is to think outside the 
box, don’t always go by the textbooks, have a system in place to cover the 'what ifs' 
because one day you will come across something that doesn’t fit the picture, and you can’t 
afford to get it wrong”  
 
- Patient’s Mother 
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